BAFNA PHARMACEUTICALS LIMITED

Altre lingue Bafna Pharmaceuticals Limited NSE India S.E.

Azioni

BAFNAPH

INE878I01014

Prezzo di chiusura NSE India S.E. Altri mercati azionari			Variaz. 5gg	Var. 1 gen.
- ^INR	-.--%		+697,75%	+207,36%

26/04	Bafna Pharmaceuticals Limited annuncia l'inaugurazione di un nuovo laboratorio di controllo qualità	CI
23/04	Bafna Pharmaceuticals Limited annuncia le dimissioni di Vishnu Vasudeva Kuppa da Segretario aziendale e Responsabile della conformità	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Bafna Pharmaceuticals Limited Announces the Inauguration of New Quality Control Laboratory	26/04
Bafna Pharmaceuticals Limited Announces Resignation of Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer	23/04
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Bafna Pharmaceuticals Resumes Commercial Production of Manufacturing Units in Chennai, India	11/12
Bafna Pharmaceuticals Limited Announces Commercial Production	08/12
Floods Disrupt Bafna Pharmaceuticals' Manufacturing Plant in Chennai, India	07/12
Bafna Pharmaceuticals Limited Announces Suspension of Chennai Production Activity Due to Impact of Michaung Cyclone	07/12
Bafna Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Bafna Pharmaceuticals Limited Announces Resignation of Kamlesh Kumar Babulal as Non-Executive Independent Director from the Board	23/09/23
Bafna Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/08/23
Bafna Pharmaceuticals Limited Approves Board Appointment	27/06/23
Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	27/05/23
Bafna Pharmaceuticals Limited Announces Appointment Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer	07/04/23
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	08/02/23
Bafna Pharmaceuticals Limited Announces Resignation of Atul Sachdeva as Director	19/01/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Assicura e Aumenta la Performance dei tuoi Investimenti con il nostro Team di Esperti al tuo fianco

Assicurare i miei Investimenti

fermer